Prof. Dr. Robert M. Goldman, MD, PhD, DO, FAASP, ABAARM

Prof. Dr. Michael Klentze, MD, PhD, ABAARM
Prof. Michael Klentze abandoned his family’s commercial traditions to commence studying medicine at Ludwig-Maximilians Universität in Munich in 1969, graduating with the grade of “excellent” in 1975. He began his training as a specialist in Neurochemistry in Munich, then moved to Göttingen and Traunstein to specialize in Gynaecology. After qualifying, he took over a panel doctor’s practice in Reutlingen and remained as its director for 11 years. During this period Prof. Klentze completed his doctorate “cum laude“ at Tübingen Urological Clinic on the subject of Urethral Syndrome. Prof. Klentze headed the Klentze Institute in Munich, Germany over 10 years as Medical Director and became head of the Department for Preventive and Regenerative Medicine of the Diagnoseklinik Muenchen in 2008. In 2009 he took over the position as International Medical Director of Vitallife Corporation a 100% subsidiary of Bumrungrad Hospital in Bangkok, Thailand, where he served as consultant over years. Prof. Klentze was the founder of the European Society of Preventive, Regenerative and Anti-Aging Medicine (ESAAM), which he served as Secretary General from 2001-2009, organized numerous conferences national and international in the same field. He is now Honorary President of ESAAM. Klentze is member of the Scientific Board of the American Academy of Anti-Aging Medicine and represents Europe for this distinguished society. He is further member of the Scientific Board of the World Society for Regenerative Medicine. He is Board Certified in Psychiatry, Diabetology and Endocrinology. He has become a Professor at the Udayana University in Denpasar Bali and the Mae Fa Luang University in Thailand in the field of Anti-Aging Medicine. His Laureate was Stem Cell reprogramming. He worked with US scientists of Chicago and Russia in the field of clinical application of stem cells and research of stem cell reprogramming. Special Fields in clinical medicine and research: Molecular biological and biochemical basics of the aging process; Endocrinology and Diabetology; metabolic disorders; prevention of age-related illnesses; regenerative stem cell treatment and research; molecular genetics; internal medicine, sports medicine, nutritional medicine, stress intervention, mood disorders. In research together with the Genosense company of Vienna, Austria; Prof. Klentze developed several modules of polymorphisms used for the risk prediction in preventive medicine. Prof. Klentze was involved in stem cell research (reprogramming stem cells) and clinical use of embryonic stem cells. Later Prof. Klentze cooperated with Dr. Vijay Sharma of Stempeutics Corp., Bangalore, India in the field of clinical use of MSC stem cells. As world wide recognized researcher in the field of clinical use of polymorphisms, Prof. Klentze lectures worldwide as well as gives seminars for preventive medicine, endocrinology, metabolic disorders. He is the author of more than 100 papers, published in peer reviewed publications and functions as author and co-author of 10 books in the field of Anti-Aging Medicine, translated into several languages.

Prof. Dr. Karl J. Neeser, PhD
Is one of Switzerland’s leading Anti-Aging Research Scientists. He earned a Masters Degree in Exercise Physiology and Physical Education, as well as a Doctorate Degree in Philosophy & Health Science. He has been a Professor at Lausanne University of Switzerland and is the Founder of two European health clubs. He has authored several books. Today he is a worldwide appreciated Health Consultant, Senior Lecturer ESAAM and Anti-Aging Medicine and lives in Switzerland and Bangkok/Thailand where he is currently a Professor at Chulalongkorn University, College of Public Health Science.

The World Health Organization now describes the prevalence of obesity as an epidemic. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 is defined as overweight, and a BMI of over 30 as obese and BMIs of 40 or more are morbidly obese. In February 2010 the CDC reported that as of 2006 percent of noninstitutionalized adults age 20 years and over who are overweight or obese: 67% and as of 2015, 75% of American adults and nearly 24 per cent of US children and adolescents will be overweight by 2015.
Current programs like diet and exercise, low carbohydrate diets, liquid protein diets, meal replacement diets etc. have had limited success in curbing the obesity epidemic. If we are truly seeking a solution to obesity, it appears we need to look elsewhere. Traditional weight loss theories and dietary and lifestyle approaches are falling far short of stemming the tide, we are drowning in fat.
Claims have been made that HCG (Human Chorionic Gonadotropin) along with a VLCD (very low calorie diet) for 30 days in a medically supervised program can reduce weight by 10-20 lbs per month along with a reduction of abdominal girth, without experiencing hunger. This workshop will demonstrate the method and result of HCG and VLCD protocol showing significant weight loss as well as reduction of abdominal girth.

Dr. Mayer Eisenstein, MD, JD, MPH, is a graduate of the University of Illinois Medical School, the Medical College of Wisconsin School of Public Health, and the John Marshall Law School. In his 37 years in medicine, he and his practice have cared for over 75,000, children, parents, and grandparents. He is the founder and Medical Director of the Homefirst® Health Services. He is Board Certified by the American Board of Public Health and Preventive Medicine, and the American Board of Quality Assurance and Utilization Review Physicians. His latest book, Making an Informed Vaccine Decision goes along with his other books: Give Birth at Home With The Home Birth Advantage; Safer Medicine, Don’t Vaccinate Before You Educate, 2nd Edition; Unavoidably Dangerous – Medical Hazards of HRT and Unlocking Nature’s Pharmacy. Some of his many guest appearances include: “The Oprah Winfrey Show” and “Hannity and Colmes”. His weekly syndicated radio show “The Dr. Mayer Eisenstein Show”, airs in the Chicagoland area. One of his goals is to lower the use of pharmaceuticals in the American population.

Essential download for Sponsor
Announcement
Exhibit & Sponsorship Proposal
Exhibition Lay Out
Preliminary Scientific Program
Exhibitor Manual

Estrogen Dominance is a very common problem in modern society. Consequently, it contributes to many presentations in clinical practice. This talk will focus on the clinical presentations in three clinical settings, namely the pre-menstrual symptoms, obesity, the post-menopausal woman and the aromatization of Estrogens in the male. The copper to zinc imbalance in Estrogen Dominance will be highlighted to explain the mood changes of pre-menstrual tension. Management of each of the thee clinical settings will be discussed, with herbs, minerals, vitamins and pharmaceutical drugs. The challenging management of the peri-menopausal women will be discussed together with the timing of Progesterone supplementation.

Dr. Nathan graduated from the University of Western Australia in 1977. After completing his residency at the Royal Perth Hospital, Dr. Nathan worked in a rural practice for 16 years, practising Emergency Medicine, Obstetrics and Gynaecology and Family Medicine during which time he completed his FRACGP and Dip. Aust COG. In 1995, Dr. Nathan completed his Fellowship in Acupuncture and in 1999 his Masters in Family Medicine. He then realised that “conventional” medicine was not providing the answers for many of his patients. Subsequently, Dr. Nathan attended his first Anti-Ageing Medicine seminar in 1999 and his first A4M Conference in Singapore in 2000. Dr. Nathan followed on to complete his Graduate Diploma in Nutrition Medicine and the Fellowship with the Australian College of Nutritional and Environmental Medicine. He opened a dedicated clinic to Anti-Ageing Medicine in 2006 and has now successfully become Board Certified in Anti-Ageing Medicine.

Option of Packages to support you undertake the ABAARM (American Board of Anti-Aging & Regenerative Medicine) Examination:

Study Package #1: ABAARM Foundation

Regular Price USD 2,500  |  Promo Price USD 1,250

•  CD Lecture Notes Asia Anti Aging Conference 2005-2008
•  DVD Video ABAARM Clinical Training Course 2007
•  DVD Video A4M-World.Asia Conference 2009-2010
•  A4M Seminars & Workshops Online Access to over 900 Slides & Audio
•  Registration Full Passport A4M-World.Asia Conference 21-23 October 2011
•  Registration “ABAARM Board Review Workshop” 21 October 2011

Who should opt for this package?

• Individuals with M.D. (Doctor of Medicine), D.O. (Doctor of Osteopathic Medicine), or M.B.B.S. (Bachelor of Medicine/Bachelor of Science) degrees interested to achieve Board Certification in Anti-Aging & Regenerative Medicine;
• Have never attended A4M Asia Conferences;
• Would like to be prepared to sit the ABAARM Part 1 Exam within 2011-2012.

Study Package #2: ABAARM Board Review

Regular Price USD 2,250  |  Promo Price USD 1,500

•  A4M Membership (1 year)
•  A4M Physician’s Guide to Anti-Aging & Regenerative Medicine
•  A4M Anti-Aging Therapeutic Volume IX, X, XI
•  A4M White Papers & Official Statement 2010
•  A4M Practice Exam Workbook 2011 (Asia Version)
•  A4M Seminars & Workshops Online Access to over 900 Slides & Audio
•  Registration Full Passport A4M-World.Asia Conference 21-23 October 2011
•  Registration “ABAARM Board Review Workshop” 21 October 2011

Who should opt for this package?

• Individuals with M.D. (Doctor of Medicine), D.O. (Doctor of Osteopathic Medicine), or M.B.B.S. (Bachelor of Medicine/Bachelor of Science) degrees interested to achieve Board Certification in Anti-Aging & Regenerative Medicine;
• Routinely attend A4M Asia Conferences;
• Would like to be prepared to sit the ABAARM Part 1 Exam within 2011-2012.

Exam Package #3: ABAARM Board Exam Part 1 or 2*special request

Regular Price USD 2,870  |  Promo Price USD 2,250

•  A4M Practice Exam Workbook 2011 (Asia Version)
•  ABAARM Online Mock Exam 2011
•  Registration Full Passport A4M-World.Asia Conference 21-23 October 2011
•  Registration “ABAARM Board Review Workshop” 21 October 2011
•  Registration ABAARM Exam Part 1 (23 Oct’11) or Part 2 (22 Oct’11)

Who should opt for this package?

• Individuals with M.D. (Doctor of Medicine), D.O. (Doctor of Osteopathic Medicine), or M.B.B.S. (Bachelor of Medicine/Bachelor of Science) degrees committed to sit ABAARM Exam Part 1 or 2 in Bali this year.
• Require an extra assisted learning through the A4M Exam Workbook and ABAARM Review Workshop Session.* Shipping fee for Study Materials applies.

Three steps to get yourself prepared for the ABAARM Part 1 Exam:

1. Plan your study well, recommended at least 3-6 months in advance, take advantage of A4M Exam Workbook (Asia Version) containing key points and mock exam questions as Study Guide. Answers to the mock exam are contained in ABAARM Board Examination Review Kit.
2. One month prior to the Exam in Bali, you will have Online Mock Practice Exam. You will have the opportunity to test yourself answering multiple choices exam questions in a timed manner as in real examination situation.
3. Mock Practice Exam result will be evaluated by Faculty staffs. You will be provided exam study preparation suggestions based on the result. The information is provided for you as a breakdown of the subject areas that you missed so that you may better focus your study efforts. Example: If the majority of your missed answers come from the Hormone subject area, you should focus your study efforts on Hormone.  If you missed no answers in Nutrition subject area, then you would need only the amount of time you felt necessary to review and refresh that area that you have proven to know well.

For any questions, please contact:
A4M-World.Asia
Customer Care: +62 817 0553 888 | +62 855 9933 899
Email: abaarm@A4M-World.Asia

Grab A4M-World.Asia 2010 Collection sets ~ a 3-days symposium and multi-workshops contained in 7 DVDs, learn from the experts, read the slides and listens to the audio! Promotion rate: USD 150 (Regular USD 299) contact@a4m-world.asia

*Shipping fee applies.

About Dr. Sanjay Kapur, MSc, PhD Scientific Director at ZRT Laboratory, Dr. Kapur is instrumental in establishing and directing various research projects for development of clinical laboratory tests. He also initiates scientific collaborations with national and international investigators interested in relevant areas of research. Dr. Kapur received his Doctorate in Life Sciences from Post Graduate Institute of Medical Education and Research, Chandigarh, India in 1993 and his second Masters degree in Business Administration from Baker College in Flint, Michigan in 2005. He has extensive experience in biomedical research and has served in several lead positions directing studies involving development of novel assays and technologies in the areas of cytotoxicity and drug metabolism. He served as Research Scientist at CHUL Research Center, Quebec, Canada, and was involved in diabetes and obesity research. He has made significant contributions in developing several QSAR’s while serving as Senior Research Scientist at Pomona College, Claremont, California where he led all research activities of the toxicology group. He has published several articles in the field of drug metabolism and signal transduction in peer reviewed national and international journals. He has strong interests in development of new testing methodologies and innovative laboratory procedures and conducts research into new applications of clinical laboratory testing at ZRT.

Lecture objectives:

• Outline the normal functions of cortisol in the body.
• Describe the types of stress situations as well as other diseases that lead to chronically increased cortisol levels.
• Discuss the effects of chronically high cortisol on body chemistry.
• List the long-term health problems that can result from these changes in body chemistry.
• Discuss specifically those factors that cause an increased risk of heart disease.
• Suggest methods to alleviate chronic stress, bring cortisol levels back to normal and promote wellness

Agenda of the specific points to be covered during the program:

• The role of cortisol as the “fight or flight” hormone and how it works to maximize the body’s ability to respond to acute stress by stimulating processes that boost energy supply to muscles and suppressing non-essential body functions
• Types of persistent stress, both emotional and physical, which contribute to maintaining high cortisol levels
• Physiological effects of chronically high cortisol, including raised blood pressure, suppressed immune function, reduced sex hormone levels, reduced growth hormone, hyperglycemia, reduced bone density, increased clotting factors
• Mechanisms by which reduced sex hormones and growth hormone, combined with hyperglycemia, lead to visceral fat deposits and insulin resistance
• The path from visceral obesity and insulin resistance to atherosclerosis and heart disease
• Other types of heart disease, e.g. heart attack, as a result of increased clotting factors, due to high cortisol
• Relaxation techniques and life changes that can be used to treat chronic stress and studies showing effects of these on cortisol levels

This session is sponsored by ZRT Laboratory, LLC (USA)

Learning Objectives:

1. Introduction to Swiss Cell Therapy – the most significant development of modern complementary, regenerative and integrative medicine.
2. An insight into the science of Thymus Therapy, Placental Therapy, Mesenchymal Therapy.
3. The safe application and indications of Thymus Therapy, Placental Therapy and Mesenchymal Therapy in aesthetic and anti-ageing regenerative medicine.

Abstract: It is imperative to greatly understand the true potential and value of Swiss Cell Therapy today. Cellular Therapy was first discovered in Switzerland in 1931 by eminent Swiss physician, Professor Dr. Paul Niehans. It has since been practiced, along with many new and proven complementary modalities, by countless other physicians primarily in Europe. This lecture will specifically focus on the regenerative powers of modern Cell Therapies, in particular Swiss Cell Therapies of Thymus, Placenta and Mesenchyme.

Thymus Therapy The thymus gland works as the central system of the body’s immune systemand it is situated behind the top part of the breastbones. It secretes three important types of cells: the helper cells, the natural killer (NK) cells and the T-suppressor cells; that are needed to destroy foreign invaders of the body. At birth, the thymus gland is very well developed; it is the biggest and single most important component of our lymphatic system at that time as the other components such as spleen and lymph nodes are just starting to develop. The thymus gland will continue to grow and develop between the time of birth and puberty. However, for reasons yet known, as a person ages, his thymus gland will start to shrink and gradually convert into connective tissue. As a result, the person’s immune system begins to weaken.

Thymus Therapy is essential in the treatment of disorders or diseases that are directly or indirectly linked to the immune system. With more than 1500 studies done on the therapeutic effects of Thymus Therapy, the use of thymus cells & peptides can help boost and regulate the immune system by improving interaction between the defense cells, activating defense cells within the body, stimulating new formation of lymphocytes in the bone marrow, helping to normalize T-cells and improving the healing of tropic ulcerations, post surgical wounds and burns.

Placental Therapy The use of placenta to improve human vitality dates back thousands of years. Deemed as life-giving and rich in vital essence, placenta is considered to be a very powerful medicine for centuries. Evidences of its existence have been written in ancient medicinal books around the world. It is, however, through modern science that scientists were able to prove, on a cellular level, the potency of Cellular Therapy time and again for the past 80 years.

Scientific research has indeed shown that placenta contains large amounts of growth factors, hormones, cytokines, antibodies and etc. All these point to the potential benefits for repair and regeneration processes in cells, tissues and organs. Clinical experience has demonstrated that treatment with placental tissue or extracts thereof can improve circulation, inhibit inflammation, enhance autonomous nervous system regulation, increase rate of wound healing and boost the immune system. Placenta is also widely used in Aesthetics as it improves skin complexion.

Mesenchymal Therapy Arose largely from the mesoderm of embryo during the early phases of mammalian gestation, mesenchyme is the mass of tissue to which most of the mammalian body’s organs and tissues are fundamentally developed from. It has the capacity to form different cell types, such as adipocytes, chondrocytes, osteocytes, hepatocytes, cardiomyocytes and neurons. Mesenchymal Therapy is widely used in Switzerland and Germany as a regenerative cell therapy to enhance the self-regulation of the inter-cellular space, brain-ageing, chronic fatigue, exhaustion from stress etc. It is most remarkably known that mesenchymal cells can instinctively migrate to the area of greatest injury in the body, become identical to the damaged cells, and then start to replicate. The mesenchyme’s abilities to differentiate and identify damaged cells can therefore effectuate potent regeneration and healing, and present numerous solutions and opportunities for anti-ageing therapies and also clinical applications.

Indications for Swiss Cellular Therapy: Anti-ageing (General Revitalisation, Rejuvenation and Youth Restoration), Adrenal Disease, Age-related Conditions, Arthritic Condition, Auditory Dysfunction, Auto Immune Condition, Blood Disorder, Diabetes Mellitus, Cardiovascular Disease, Circulatory Problems, Immune System Dysfunction, Kidney Disease, Liver Disease etc.

In 1997, this research group demonstrated that SGS content of mature broccoli was highly variable. Further, there is no way for consumers to detect this variability and know whether they are getting high-concentration broccoli or not. Thus a system was created to grow, develop and harvest broccoli specifically for the extraction and use of SGS for health related conditions.

Since 1992, SGS has been extensively studied at Johns Hopkins and other prestigious medical institutions around the globe. More than 400 studies have been published which support the possible health benefits of SGS.

SGS works as a potent catalyst to boost Phase 2 enzymes in the body. These detoxification enzymes trigger ongoing antioxidant action for at least 72 hours. As a result, the indirect antioxidant activity of SGS lasts significantly longer than that of direct antioxidants such as vitamins C, E and beta carotene. Furthermore, 3-day-old sprouts have a much higher concentration of SGS than the average mature broccoli (73 mg v. 11 mg per serving, respectively), which means that one ounce of broccoli sprouts contains as much SGS as over 1-1/4 pounds (20 ounces) of market-stage broccoli.

The body of scientific knowledge concerning SGS and broccoli sprouts continues to grow at a rapid rate; key studies with respect to SGS are summarized below.

Summaries of some key studies follow:

• Carcinogen Detoxification
• Tumor Progression and Activity
• Stomach Cancer
• Skin Tumors
• Breast Cancer
• Prostate Cancer
• Colon Cancer
• Bladder Cance
• Impact on Developing or Developed Cancers

OTHER HEALTH CONDITIONS:

• Cholesterol Levels
• High Blood Pressure
• Macular Degeneration

Contact us if you are interested to get the literatures.

Register to A4M-World.Asia 21-23 October 2011 to learn more from the Expert:

Cheryl Burdette, N.D. received her Doctor of Naturopathy degree from Bastyr University in 2001. She completed her residency at Cancer Treatment Centers of America. Dr. Burdette is currently in private practice in Atlanta, Georgia at Progressive Medical Center, one of the largest Integrative Medicine clinics in the Southeast. She has been the director of the only naturopathic residency program in the U.S. that trained in functional medicine and nutritional biochemistry. She serves on an IRB board and reviews studies related to complementary and alternative therapies. Dr. Burdette is one of the authors of the book, Laboratory Evaluations in Molecular Medicine and has published in many journals including Alternative Medicine Review and Clinical Chemistry. She is an often-sought speaker and is invited yearly to present at Grand Rounds at all of the Naturopathic medical schools in the country. Dr. Cheryl Burdette has been a member of the BOA for Xymogen since 2009. She is also president and education director of NutraTest Labs. In this position she is involved in clinical trials of different nutraceutical products as well as development of functional testing profiles. Her marriage between clinical practice and laboratory oversight, gives her a unique perspective in evidence-based natural therapies.

• Appropriate selection of patients to be treated with the Oral hCG™ method
• Clinical exams to evaluate propspective patients
• Information management during treatment
• Special characteristics of every treatment week

Dr. Daniel Oscar Belluscio The hCG Research Center, Buenos Aires, ARGENTINA

The Oral hCG Research Center is a foundational member of the International Society for Alternative Uses of human Choriogonadotropin (ISAUC)

For many years the hCG program for weight loss enjoyed worldwide popularity due to the excellent obtained results . Daily administration of 125 IU of hCG plus a Very Low Calorie Diet (VLCD) Diet rapidly decreased body weight without any side effects. Hundreds of thousands of patients benefited from this safe and effective weight reduction program.

Obesity has now reached worldwide proportions, and society faces a problem that will cause more suffering, disease and death than any other plague over the last three hundred years. The hCG method may well be a safe and effective alternative for treating those millions of individuals suffering obesity.

hCG is one of the few drugs of natural origin that, fortunately, still remain in the current Pharmacopoeia. For unknown reasons, most of the research performed on its therapeutic potential deals with investigations related to testicles or ovaries, with comparatively few investigations performed in other clinical fields.

Secreted by the placenta, the presence of hCG in the urine of pregnant women was first reported by Ascheim and Zondek in 1927. Since then, thousands of articles have been published about the effect of hCG on gonads (testicles or ovaries), but comparatively a small number of these have investigated its vast therapeutic potential on diseases ranging from Kaposi sarcoma,to asthma, psychoses, artheriopaties, thalassemia, osteopenia, glaucoma, cancer. hCG proved to be effective in the above-mentioned conditions, but insufficient data were gathered to conclusively determine its clinical utility.

To complicate the situation even more, the use of hCG in the treatment of obesity has been the subject of controversy. The results of a series of studies were interpreted to mean that hCG should not be used for the treatment of obesity, notwithstanding reports from many patients who had been treated with the hCG protocol referred they were completely satisfied with the method and the obtained results (See Opinions).

The objective of The International Society for Alternative Uses of human Choriogonadotropin (ISAUC) is to create a climate of favorable opinion aimed at bringing hCG back into the scientific consideration of Researchers and the public.